Comparison of Vaccine Adverse Events Between Zoster Vaccine Live and Recombinant Zoster Vaccine: A Prospective Multicenter Survey

U.S. Food & Drug Administration. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. Updated 2007. Accessed January 6, 2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/toxicity-grading-scale-healthy-adult-and-adolescent-volunteers-enrolled-preventive-vaccine-clinical

[12]

Sullivan Vaccine (2023) 10.1016/j.vaccine.2022.10.063

[13]

Chlibek Vaccine (2014) 10.1016/j.vaccine.2014.01.019

[14]

Willis Vaccine (2017) 10.1016/j.vaccine.2017.11.013

[15]

Fiore Ther Adv Vaccines Immunother (2021) 10.1177/25151355211057479

[16]

Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis

Yue Xia, Liuren Zhang, Chuanxi Fu

Frontiers in Immunology 2022 10.3389/fimmu.2022.978203

[17]

Goud JAMA Intern Med (2021) 10.1001/jamainternmed.2021.6227

[18]

Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence

Raunak Parikh, David Singer, Elizabeth Chmielewski-Yee et al.

Human Vaccines & Immunotherapeutics 2023 10.1080/21645515.2023.2263979

[19]

Yih Am J Epidemiol (2022) 10.1093/aje/kwac030

[20]

Choi J Korean Med Sci (2016) 10.3346/jkms.2016.31.1.13

[21]

Park Lancet Rheumatol (2024) 10.1016/s2665-9913(24)00084-5

Metrics

0

Citations

21

References

Details

Published: Jan 01, 2026
Vol/Issue: 41(14)
License: View

Authors

J

Jin Gu Yoon

Division of Infectious Diseases, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea.; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea.

E

Eliel Nham

Division of Infectious Diseases, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea.; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea.

Y

Yu Jung Choi

Division of Infectious Diseases, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea.; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea.

W

Won Suk Choi

Division of Infectious Diseases, Department of Internal Medicine, Ansan Hospital, Korea University College of Medicine, Ansan, Korea.

M

Min Joo Choi

Department of Internal Medicine, International St. Mary’s Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.

Y

Yu Bin Seo

Division of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

J

Jacob Lee

Division of Infectious Diseases, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.

H

Hakjun Hyun

Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Korea.

J

Jung Yeon Heo

Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Korea.

J

Ji Yun Noh

Division of Infectious Diseases, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea.; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea.

J

Joon Young Song

Division of Infectious Diseases, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea.; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea.

H

Hee Jin Cheong

Division of Infectious Diseases, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, Korea.; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul, Korea.

Funding

Ministry of Food and Drug Safety of Korea Award: 22183MFDS435

Cite This Article

Jin Gu Yoon, Eliel Nham, Yu Jung Choi, et al. (2026). Comparison of Vaccine Adverse Events Between Zoster Vaccine Live and Recombinant Zoster Vaccine: A Prospective Multicenter Survey. Journal of Korean Medical Science, 41(14). https://doi.org/10.3346/jkms.2026.41.e111

Comparison of Vaccine Adverse Events Between Zoster Vaccine Live and Recombinant Zoster Vaccine: A Prospective Multicenter Survey

You May Also Like